Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany.
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians Universität München, Munich, Germany.
J Neurol. 2024 Nov;271(11):7222-7231. doi: 10.1007/s00415-024-12666-w. Epub 2024 Sep 9.
Optic neuritis (ON) is a common manifestation of multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein IgG-associated disease (MOGAD). This study evaluated the applicability of optical coherence tomography (OCT) for differentiating between both diseases in two independent cohorts.
One hundred sixty two patients from seven sites underwent standard OCT and high-contrast visual acuity (HCVA) testing at least 6 months after first ON. Of these, 100 patients (32 MOGAD, 68 MS) comprised the primary investigational cohort, while 62 patients (31 MOGAD, 31 MS) formed a validation cohort. A composite score distinguishing between MOGAD and MS was developed using multivariate logistic regression.
Bilateral simultaneous ON occurred more frequently in MOGAD compared to MS (46.9 vs. 11.8%, p < 0.001). OCT revealed more peripapillary retinal nerve fiber layer (pRNFL) atrophy in all segments in MOGAD compared to predominantly temporal pRNFL atrophy in MS (p < 0.001). HCVA was better preserved in MS (p = 0.007). pRNFL thickness in all except for temporal segments was suitable for differentiating MOGAD and MS. Simultaneous bilateral ON and critical atrophy in nasal (< 58.5 µm) and temporal superior (< 105.5 µm) segments were included into the composite score as three independent predictors for MOGAD. The composite score distinguished MOGAD from MS with 75% sensitivity and 90% specificity in the investigational cohort, and 68% sensitivity and 87% specificity in the validation cohort.
Following a single ON-episode, MOGAD exhibits more pronounced global pRNFL atrophy and lower visual acuity after ON compared to MS. The introduced OCT-based composite score enabled differentiation between the two entities across both cohorts.
视神经炎(ON)是多发性硬化症(MS)和髓鞘少突胶质细胞糖蛋白 IgG 相关疾病(MOGAD)的常见表现。本研究在两个独立队列中评估了光相干断层扫描(OCT)在区分这两种疾病中的适用性。
来自七个地点的 162 名患者在首次 ON 后至少 6 个月进行了标准 OCT 和高对比度视力(HCVA)测试。其中,100 名患者(32 名 MOGAD,68 名 MS)构成了主要研究队列,而 62 名患者(31 名 MOGAD,31 名 MS)构成了验证队列。使用多元逻辑回归建立了区分 MOGAD 和 MS 的复合评分。
MOGAD 中双侧同时性 ON 的发生率高于 MS(46.9% vs. 11.8%,p<0.001)。OCT 显示 MOGAD 中所有节段的视盘周围视网膜神经纤维层(pRNFL)萎缩程度均高于 MS 中主要为颞侧 pRNFL 萎缩(p<0.001)。MS 中 HCVA 保存更好(p=0.007)。除颞段外,所有节段的 pRNFL 厚度均适合区分 MOGAD 和 MS。同时双侧性 ON 和鼻侧(<58.5 µm)和颞上(<105.5 µm)节段的临界性萎缩被纳入复合评分,作为 MOGAD 的三个独立预测因子。该复合评分在研究队列中区分 MOGAD 和 MS 的敏感性为 75%,特异性为 90%,在验证队列中的敏感性为 68%,特异性为 87%。
在单次 ON 发作后,MOGAD 比 MS 表现出更明显的全局 pRNFL 萎缩和 ON 后更低的视力。引入的基于 OCT 的复合评分能够区分两个实体。